abstract |
A drug suitable for propellant and lung inhalation comprising a first particulate material comprising particles having an average aerodynamic diameter of 0.05-11 μm and a second particulate material comprising particles having an average volume diameter of 15-200 μm. An aerosol composition is provided. The presence of the second particulate material provides good suspension properties, especially when the propellant is hydrofluoro alkanes. |